Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy

• Published in: Biomaterials 2016-02, Vol.80, p.157-168
• Main Authors: Joanne, Pierre, Kitsara, Maria, Boitard, Solène-Emmanuelle, Naemetalla, Hany, Vanneaux, Valérie, Pernot, Mathieu, Larghero, Jérôme, Forest, Patricia, Chen, Yong, Menasché, Philippe, Agbulut, Onnik
• Format: Article
• Language: English
• Subjects: Advanced Basic Science; Animals; Cardiac cell therapy; Cardiology and cardiovascular system; Cardiomyopathy; Cardiomyopathy, Dilated - physiopathology; Cardiomyopathy, Dilated - therapy; Cell Line; Cellular Biology; Collagen - chemistry; Collagen scaffold; Crosslinking; Dentistry; Electrospinning; Heart - physiology; Heart - physiopathology; Human; Human health and pathology; Humans; Implantation; Induced pluripotent stem cells; Induced Pluripotent Stem Cells - cytology; Life Sciences; Mice; Mice, Inbred C57BL; Myocytes, Cardiac - cytology; Myocytes, Cardiac - transplantation; Nanofibers - chemistry; Nanostructure; Remodeling; Scaffolds; Tissue Scaffolds - chemistry
• ISSN: 0142-9612; 1878-5905
• DOI: 10.1016/j.biomaterials.2015.11.035

Abstract Limited data are available on the effects of stem cells in non-ischemic dilated cardiomyopathy (DCM). Since the diffuse nature of the disease calls for a broad distribution of cells, this study investigated the scaffold-based delivery of human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CM) in a mouse model of DCM. Nanofibrous scaffolds were produced using a clinical grade atelocollagen which was electrospun and cross-linked under different conditions. As assessed by scanning electron microscopy and shearwave elastography, the optimum crosslinking conditions for hiPS-CM colonization proved to be a 10% concentration of citric acid crosslinking agent and 150 min of post-electrospinning baking. Acellular collagen scaffolds were first implanted in both healthy mice and those with induced DCM by a cardiac-specific invalidation of serum response factor (SRF). Seven and fourteen days after implantation, the safety of the scaffold was demonstrated by echocardiography and histological assessments. The subsequent step of implantation of the scaffolds seeded with hiPS-CM in DCM induced mice, using cell-free scaffolds as controls, revealed that after fourteen days heart function decreased in controls while it remained stable in the treated mice. This pattern was associated with an increased number of endothelial cells, in line with the greater vascularity of the scaffold. Moreover, a lesser degree of fibrosis consistent with the upregulation of several genes involved in extracellular matrix remodeling was observed. These results support the interest of the proposed hiPS-CM seeded electrospun scaffold for the stabilization of the DCM outcome with potential for its clinical use in the future.